1. A review of current models for initiating injectable therapy for people with type 2 diabetes in primary care
- Author
-
Toni Rice, Rajna Ogrin, and Arti Appannah
- Subjects
medicine.medical_specialty ,endocrine system diseases ,Type two diabetes ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Type 2 diabetes ,Primary care ,Review ,lcsh:Diseases of the endocrine glands. Clinical endocrinology ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Insulin initiation ,Nursing ,Nurse-led models of care ,medicine ,030212 general & internal medicine ,Limited evidence ,lcsh:RC648-665 ,business.industry ,Injectable therapy ,fungi ,Type 2 Diabetes Mellitus ,food and beverages ,medicine.disease ,Home setting ,Family medicine ,business - Abstract
Highlights • Nurse-led models of initiating injectable therapy in primary care are successful. • Education to GPs and nurses can assist initiation of injectable therapy. • Nurse-led patient group education can support initiating injectable therapy., Aims To systematically identify and describe models of injectable therapy initiation for people with type 2 diabetes mellitus (T2DM) in primary care. Methods Eight electronic databases and the grey literature were searched. Studies examining models of injectable therapy initiation for adults with T2DM in primary care settings were included. Results Successful models included: 1) Nurse-led one-to-one approach; 2) Nurse-led group sessions; and 3) Providing education to GPs and nurses. Conclusions Few robust studies were found. Studied models were mainly in general practices, with limited evidence documented about starting people with T2DM on an injectable in the home setting.
- Published
- 2017